Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway
Name
Ando-2017-Camptothecin resistance is determine.pdf
Size
2.23 MB
Format
Adobe PDF
Checksum (MD5)
98ab2e9e47839c429cd416c0aaaf89db
Author(s)
Ando, Koji
Shah, Ankur K.
Sachdev, Vibhu
Kleinstiver, Benjamin P.
Taylor-Parker, Julian
Welch, Moira M.
Hu, Yiheng
Salgia, Ravi
Parvin, Jeffrey D.
Ozonoff, Al
Date Issued
March 2017
Journal
Oncotarget
Publisher
Impact Journals/National Center for Biotechnology Information (U.S.)
Citation
Ando, Koji; Shah, Ankur K.; Sachdev, Vibhu; Kleinstiver, Benjamin P.; Taylor-Parker, Julian; Welch, Moira M.; Hu, Yiheng et al. “Camptothecin Resistance Is Determined by the Regulation of Topoisomerase I Degradation Mediated by Ubiquitin Proteasome Pathway.” Oncotarget (November 2015): 16376
Version
Final published version
Abstract
Proteasomal degradation of topoisomerase I (topoI) is one of the most remarkable cellular phenomena observed in response to camptothecin (CPT). Importantly, the rate of topoI degradation is linked to CPT resistance. Formation of the topoI-DNA-CPT cleavable complex inhibits DNA re-ligation resulting in DNA-double strand break (DSB). The degradation of topoI marks the first step in the ubiquitin proteasome pathway (UPP) dependent DNA damage response (DDR). Here, we show that the Ku70/Ku80 heterodimer binds with topoI, and that the DNA-dependent protein kinase (DNA-PKcs) phosphorylates topoI on serine 10 (topoI-pS10), which is subsequently ubiquitinated by BRCA1. A higher basal level of topoI-pS10 ensures rapid topoI degradation leading to CPT resistance. Importantly, PTEN regulates DNA-PKcs kinase activity in this pathway and PTEN deletion ensures DNA-PKcs dependent higher topoI-pS10, rapid topoI degradation and CPT resistance.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution 3.0 Unported license
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.18632/oncotarget.16376
